Abstract
BackgroundTranscatheter aortic valve implantation (TAVI) shown its efficacy to be mainstay treatment for aortic valve diseases over surgical options, yet postoperative antiplatelet regimen after TAVI is still debatable. Thus, the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
